Advances in Down syndrome research /
Animal models.
| Other Authors: | |
|---|---|
| Format: | Book |
| Language: | English |
| Published: |
Wien ; New York :
Springer,
2003.
|
| Series: | Journal of neural transmission. Supplementum ;
67. |
| Subjects: |
Table of Contents:
- A new mouse model for Down Syndrome
- Predicting pathway perturbations in Down Syndrome
- Aberrant protein expresssion of transcription factors BACH1 and ERG, both encoded on chromosome 21, in brains of patients with Down Syndrome and Alzheimer's disease
- Cell cycle and cell size regulation in Down Syndrome cells
- Transcription factor REST dependent proteins are comparable between Down syndrome and control brains: challenging a hypothesis
- An altered antioxidant balance occurs in down Syndrome fetal organs : implications for the "gene dosage effect" hypothesis
- Overexpression of C1-tetrahydrofolate synthase in fetal Down Syndrome brain
- Increased expression of human reduced folate carrier in fetal Down Syndrome brain
- Chromosome 21 KIR channels in brain development
- Reduction of chromatin assembly factor 1 p60 and C21orf2 protein, encoded on chromosome 21, in Down Syndrome brain
- The MNB/DYRK1A protein kinase : neurobiological functions and Down Syndrome implications
- The MNB/DYRK1A protein kinase : genetic and biochemical properties
- Cytoskeleton derangement in brain of patients with Down Syndrome, Alzheimer's disease and Pick's disease
- The cerebral cortex in Fetal Down Syndrome
- Polysomnography in transgenic hSOD1 mice as Down Syndrome model
- Spectrum of cognitive, behavioural and emotional problems in children and young adults with Down Syndrome
- Overexpression of transcription factor BACH1 in Fetal Down Syndrome brain
- Down Syndrome and associated congenital malformations
- RNA microarray analysis of channels and transporters in normal and Fetal Down Syndrome (trisomy 21) brain
- Heart type fatty acid binding protein (H-FABP) is decreased in brains of patients with Down Syndrome and Alzheimer's disease
- Stem cell marker expression in human trisomy 21 amniotic fluid cells and trophoblasts